Jump to content
AskTraders Trading Community
  • 0

How did BioPharmX do in Q1?


Craig Nicholas

Question

1 answer to this question

Recommended Posts

  • 0
BioPharmX Corporation reported its Q1 2020 financial results, reporting an overall better performance than the last year. However, the results cannot be considered good yet. The pharmaceutical company reported smaller net losses and less operating expenses compared to the previous year. BioPharmX’s total operating expenses for the reported quarter were $3.6m. This figure can be compared with total operating expenses of $4.4m, which were reported in the previous year’s quarter. Net losses were reported to be $3.6 million, and the figure is an improvement to the previous year’s result of $4.4 million. Looking at it from a per-share perspective, this year’s net loss per share is $0.38. On the other hand, the previous year’s result was $0.61 per share. Non-GAAP net losses got reported to be $0.36 per share versus $0.52 per share from the previous year’s quarter.
Link to comment
Share on other sites

Join the conversation

You can post now and register later. To reply to this question, sign in or create a new account.

Guest
Reply to this question

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...